Lung Cancer Clinical Trials in San Antonio, TX

Lung Cancer Clinical Trials in San Antonio, TX

View the best 10 lung cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Lung Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for lung cancer in San Antonio, Texas

Image of Carolina BioOncology Institute /ID# 232597 in Huntersville, United States.

ABBV-514 +2 More

Immunotherapy

Recruiting1 awardPhase 1
This trial is testing two experimental drugs, ABBV-514 and Budigalimab, on adults with specific types of cancer. The goal is to find out if these drugs can help treat lung and head/neck cancers by monitoring their effects and side effects.
Image of Research Site in Bellflower, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether adding chemotherapy to osimertinib will help people with non-small cell lung cancer that has a specific DNA mutation and has gotten worse despite osimertinib.
Image of City of Hope Cancer Center; Division of Medical Oncology & Experimental Therapeutics in Duarte, United States.

Atezolizumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will test a new two-drug combo as a possible treatment for lung cancer. The drugs will be given before surgery, and then again after surgery if it is successful.
Image of University of California San Diego, 3855 Health Sciences Drive, Mc 0987 in La Jolla, United States.

Itacitinib +1 More

Janus Kinase (JAK) Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the safety of using two drugs, itacitinib and osimertinib, together. The study focuses on patients with advanced lung cancer that has spread. Itacitinib helps the immune system fight cancer, while osimertinib targets and kills specific cancer cells. Osimertinib is approved for treating a specific type of lung cancer, even in cases where the cancer has become resistant to other treatments.
Image of Research Site in Mesa, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new immunotherapy drug combo to see if it's more effective than just one of the drugs for treating lung cancer that has spread and can't be removed by surgery.
Image of Investigational Site Number 8400024 in Tucson, United States.

tusamitamab ravtansine +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is studying tusamitamab ravtansine to see how well it works compared with docetaxel in treating patients with non-small cell lung cancer that has come back or spread and express CEACAM5.
Image of City of Hope Cancer Center in Duarte, United States.

Tepotinib

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will study the effects of tepotinib on lung cancer growth and spread, as well as safety, side effects, and quality of life. Pharmacogenetic research may also be conducted to study how genes impact the effectiveness of the drug.
Image of Hematology Oncology Associates of CNY, PC in East Syracuse, United States.

Adagrasib

Small Molecule Drug

Recruiting1 awardPhase 2
This trial tests a drug combo to treat advanced lung cancer with a genetic mutation.
Image of Dana Farber Cancer Institute in Boston, United States.

Avutometinib (VS-6766) +1 More

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial will study the safety and effectiveness of VS-6766 when used with sotorasib in patients with a specific type of lung cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.